Sensitivity of anterior pituitary hormones to irradiation

References

• Kirsch DG, Tarbell NJ. Conformal radiation therapy for childhood CNS tumors. Oncologist9, 442–450 (2004).
   PubMed Web of Science ®Google Scholar
• Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q. J. Med.70, 145–160 (1989).
   PubMedGoogle Scholar
• Lam KS, Tse VK, Wang C, Yeung RT, Ho JH. Effects of cranial irradiation on hypothalamic–pituitary function – a 5-year longitudinal study in patients with nasopharyngeal carcinoma. Q. J. Med.78, 165–176 (1991).
   PubMedGoogle Scholar
• Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML. Radiation-induced hypopituitarism is dose-dependent. Clin. Endocrinol.31, 363–373 (1989).
   PubMed Web of Science ®Google Scholar
• Brennan BM, Rahim A, Mackie EM, Eden OB, Shalet SM. Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin. Endocrinol.48, 777–783 (1998).
   PubMed Web of Science ®Google Scholar
• Adan L, Trivin C, Sainte-Rose C, Zucker JM, Hartmann O, Brauner R. GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults. J. Clin. Endocrinol. Metab.86, 5245–5251 (2001).
   PubMed Web of Science ®Google Scholar
• Agha A, Sherlock M, Brennan S et al. hypothalamic–pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J. Clin. Endocrinol. Metab.90, 6355–6360 (2005).
   PubMed Web of Science ®Google Scholar
• Barendsen GW. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int. J. Radiat. Oncol. Biol. Phys.8, 1981–1997 (1982).
   PubMed Web of Science ®Google Scholar
• Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol.62, 679–694 (1989).
   PubMed Web of Science ®Google Scholar
• Schmiegelow M, Lassen S, Poulsen HS et al. Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study. Clin. Endocrinol.53, 191–197 (2000).
   PubMed Web of Science ®Google Scholar
• Bentzen SM. Quantitative clinical radiobiology. Acta Oncol.32, 259–275 (1993).
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Overgaard M, Overgaard J. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Eur. J. Cancer29A, 1373–1376 (1993).
   PubMed Web of Science ®Google Scholar
• Yaes RJ. LQ and time model. Radiother. Oncol.21, 143–144 (1991).
   PubMedGoogle Scholar
• Yaes RJ, Patel P, Maruyama Y. On using the linear-quadratic model in daily clinical practice. Int. J. Radiat. Oncol. Biol. Phys.20, 1353–1362 (1991).
   PubMedGoogle Scholar
• Thames HD, Hendry JH, Moore JV, Ang KK, Travis EL. The high steepness of dose-response curves for late-responding normal tissues. Radiother. Oncol.15, 49–53 (1989).
   PubMed Web of Science ®Google Scholar
• Duffner PK, Cohen ME, Voorhess ML et al. Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study. Cancer56, 2189–2193 (1985).
   PubMedGoogle Scholar
• Clayton PE, Shalet SM. Dose dependency of time of onset of radiation-induced growth hormone deficiency. J. Pediatr.118, 226–228 (1991).
   PubMed Web of Science ®Google Scholar
• Littley MD, Shalet SM, Morgenstern GR, Deakin DP. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Q. J. Med.78, 265–274 (1991).
   PubMedGoogle Scholar
• Ogilvy-Stuart AL, Clark DJ, Wallace WH et al. Endocrine deficit after fractionated total body irradiation. Arch. Dis. Child.67, 1107–1110 (1992).
   PubMed Web of Science ®Google Scholar
• Brauner R, Rappaport R, Prevot C et al. A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth. J. Clin. Endocrinol. Metab.68, 346–351 (1989).
   PubMed Web of Science ®Google Scholar
• Spoudeas HA, Charmandari E, Brook CG. Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours. Med. Pediatr. Oncol.40, 224–229 (2003).
   PubMedGoogle Scholar
• Livesey EA, Hindmarsh PC, Brook CG et al. Endocrine disorders following treatment of childhood brain tumours. Br. J. Cancer61, 622–625 (1990).
   PubMed Web of Science ®Google Scholar
• Foote KD, Friedman WA, Buatti JM, Bova FJ, Meeks SA. Linear accelerator radiosurgery in brain tumor management. Neurosurg. Clin. N. Am.10, 203–242 (1999).
   PubMedGoogle Scholar
• Laws ER Jr, Vance ML. Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg. Clin. N. Am.10, 327–336 (1999).
   PubMed Web of Science ®Google Scholar
• Colin P, Jovenin N, Delemer B et al. Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int. J. Radiat. Oncol. Biol. Phys.62, 333–341 (2005).
   PubMed Web of Science ®Google Scholar
• Sklar CA, Constine LS. Chronic neuroendocrinological sequelae of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys.31, 1113–1121 (1995).
   PubMedGoogle Scholar
• Constine LS, Woolf PD, Cann D et al. hypothalamic–pituitary dysfunction after radiation for brain tumors. N. Engl. J. Med.328, 87–94 (1993).
   PubMed Web of Science ®Google Scholar
• Shalet SM, Clayton PE, Price DA. Growth and pituitary function in children treated for brain tumours or acute lymphoblastic leukaemia. Horm. Res.30, 53–61 (1988).
   PubMed Web of Science ®Google Scholar
• Sklar CA. Growth and pubertal development in survivors of childhood cancer. Pediatrician18, 53–60 (1991).
   PubMedGoogle Scholar
• Chrousos GP, Poplack D, Brown T, O'Neill D, Schwade J, Bercu BB. Effects of cranial radiation on hypothalamic-adenohypophyseal function: abnormal growth hormone secretory dynamics. J. Clin. Endocrinol. Metab.54, 1135–1139 (1982).
   PubMedGoogle Scholar
• Samaan NA, Bakdash MM, Caderao JB, Cangir A, Jesse RH Jr, Ballantyne AJ. Hypopituitarism after external irradiation. Evidence for both hypothalamic and pituitary origin. Ann. Intern. Med.83, 771–777 (1975).
   PubMed Web of Science ®Google Scholar
• Blacklay A, Grossman A, Ross RJ et al. Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone release. J. Endocrinol.108, 25–29 (1986).
   PubMed Web of Science ®Google Scholar
• Lam KS, Wang C, Yeung RT et al. Hypothalamic hypopituitarism following cranial irradiation for nasopharyngeal carcinoma. Clin. Endocrinol.24, 643–651 (1986).
   PubMedGoogle Scholar
• Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J. Clin. Endocrinol. Metab.88, 95–102 (2003).
   PubMed Web of Science ®Google Scholar
• Guo YP, Hendry JH, Morris ID, Davis JR, Beardwell CG. Cell proliferation and death in the irradiated pituitary gland and its modification by growth stimulants. Int. J. Radiat. Oncol. Biol. Phys.38, 175–181 (1997).
   PubMed Web of Science ®Google Scholar
• Vincent PC. Apoptosis and the assessment of radiation injury. Stem Cells13(Suppl. 1), 153–164 (1995).
   PubMedGoogle Scholar
• Dainiak N. Mechanisms of radiation injury: impact of molecular medicine. Stem Cells15(Suppl. 2), 1–5 (1997).
   PubMedGoogle Scholar
• Nishioka H, Hirano A, Haraoka J, Nakajima N. Histological changes in the pituitary gland and adenomas following radiotherapy. Neuropathology22, 19–25 (2002).
   PubMed Web of Science ®Google Scholar
• Nishioka H, Ito H, Haraoka J, Hirano A. Histological changes in the hypofunctional pituitary gland following conventional radiotherapy for adenoma. Histopathology38, 561–566 (2001).
   PubMedGoogle Scholar
• Rodemann HP, Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother. Oncol.35, 83–90 (1995).
   PubMed Web of Science ®Google Scholar
• Vankelecom H, Matthys P, Van Damme J, Heremans H, Billiau A, Denef C. Immunocytochemical evidence that S-100-positive cells of the mouse anterior pituitary contain interleukin-6 immunoreactivity. J. Histochem. Cytochem.41, 151–156 (1993).
   PubMedGoogle Scholar
• Robinson IC, Fairhall KM, Hendry JH, Shalet SM. Differential radiosensitivity of hypothalamo-pituitary function in the young adult rat. J. Endocrinol.169, 519–526 (2001).
   PubMed Web of Science ®Google Scholar
• Hochberg Z, Kuten A, Hertz P, Tatcher M, Kedar A, Benderly A. The effect of single-dose radiation on cell survival and growth hormone secretion by rat anterior pituitary cells. Radiat. Res.94, 508–512 (1983).
   PubMedGoogle Scholar
• Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr. Res.25, 561–567 (1989).
   PubMed Web of Science ®Google Scholar
• Toogood AA, Ryder WD, Beardwell CG, Shalet SM. The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status. Clin. Endocrinol.43, 97–103 (1995).
   PubMedGoogle Scholar
• Iranmanesh A, Grisso B, Veldhuis JD. Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay. J. Clin. Endocrinol. Metab.78, 526–535 (1994).
   PubMedGoogle Scholar
• Reutens AT, Veldhuis JD, Hoffman DM, Leung KC, Ho KK. A highly sensitive growth hormone (GH) enzyme-linked immunosorbent assay uncovers increased contribution of a tonic mode of GH secretion in adults with organic GH deficiency. J. Clin. Endocrinol. Metab.81, 1591–1597 (1996).
   PubMedGoogle Scholar
• Baum HB, Biller BM, Katznelson L et al. Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men – a clinical research center study. J. Clin. Endocrinol. Metab.81, 84–92 (1996).
   PubMed Web of Science ®Google Scholar
• Darzy KH, Pezzoli SS, Thorner MO, Shalet SM. The dynamics of growth hormone (GH) secretion in adult cancer survivors with severe GH deficiency acquired after brain irradiation in childhood for nonpituitary brain tumors: evidence for preserved pulsatility and diurnal variation with increased secretory disorderliness. J. Clin. Endocrinol. Metab.90, 2794–2803 (2005).
   PubMed Web of Science ®Google Scholar
• Darzy KH, Murray RD, Gleeson HK, Pezzoli SS, Thorner MO, Shalet SM. The impact of short-term fasting on the dynamics of 24-hour GH secretion in patients with severe radiation-induced GH deficiency. J. Clin. Endocrinol. Metab.91(3), 987–994 (2005).
   PubMedGoogle Scholar
• Rappaport R, Brauner R, Czernichow P et al. Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J. Clin. Endocrinol. Metab.54, 1164–1168 (1982).
   PubMed Web of Science ®Google Scholar
• Toogood AA. Endocrine consequences of brain irradiation. Growth. Horm. IGF Res.14(Suppl. A), S118–S124 (2004).
   Google Scholar
• Bath LE, Anderson RA, Critchley HO, Kelnar CJ, Wallace WH. hypothalamic–pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Hum. Reprod.16, 1838–1844 (2001).
   PubMed Web of Science ®Google Scholar
• Muller J. Disturbance of pubertal development after cancer treatment. Best Pract. Res. Clin. Endocrinol. Metab.16, 91–103 (2002).
   PubMedGoogle Scholar
• Leiper AD, Stanhope R, Kitching P, Chessells JM. Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch. Dis. Child.62, 1107–1112 (1987).
   PubMed Web of Science ®Google Scholar
• Ogilvy-Stuart AL, Clayton PE, Shalet SM. Cranial irradiation and early puberty. J. Clin. Endocrinol. Metab.78, 1282–1286 (1994).
   PubMedGoogle Scholar
• Roth C, Schmidberger H, Schaper O et al. Cranial irradiation of female rats causes dose-dependent and age-dependent activation or inhibition of pubertal development. Pediatr. Res.47, 586–591 (2000).
   PubMedGoogle Scholar
• Roth C, Lakomek M, Schmidberger H, Jarry H. Cranial irradiation induces premature activation of the gonadotropin-releasing-hormone. Klin. Padiatr.213, 239–243 (2001).
   PubMedGoogle Scholar
• Roth C, Schmidberger H, Lakomek M, Witt O, Wuttke W, Jarry H. Reduction of gamma-aminobutyric acid-ergic neurotransmission as a putative mechanism of radiation induced activation of the gonadotropin releasing-hormone-pulse generator leading to precocious puberty in female rats. Neurosci. Lett.297, 45–48 (2001).
   PubMedGoogle Scholar
• Groot-Loonen JJ, van Setten P, Otten BJ, van’t Hof MA, Lippens RJ, Stoelinga GB. Shortened and diminished pubertal growth in boys and girls treated for acute lymphoblastic leukaemia. Acta Paediatr.85, 1091–1095 (1996).
   PubMed Web of Science ®Google Scholar
• Hokken-Koelega AC, van Doorn JW, Hahlen K, Stijnen T, de Muinck Keizer-Schrama SM, Drop SL. Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: a comparative study. Pediatr. Res.33, 577–582 (1993).
   PubMed Web of Science ®Google Scholar
• Didcock E, Davies HA, Didi M, Ogilvy Stuart AL, Wales JK, Shalet SM. Pubertal growth in young adult survivors of childhood leukemia. J. Clin. Oncol.13, 2503–2507 (1995).
   PubMed Web of Science ®Google Scholar
• Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med. Pediatr. Oncol.33, 2–8 (1999).
   PubMedGoogle Scholar
• Rose SR, Schreiber RE, Kearney NS et al. Hypothalamic dysfunction after chemotherapy. J. Pediatr. Endocrinol. Metab.17, 55–66 (2004).
   PubMed Web of Science ®Google Scholar
• Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Lange M, Poulsen HS, Muller J. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. J. Clin. Endocrinol. Metab.88, 3149–3154 (2003).
   PubMedGoogle Scholar
• Arlt W, Hove U, Muller B et al. Frequent and frequently overlooked: treatment-induced endocrine dysfunction in adult long-term survivors of primary brain tumors. Neurology49, 498–506 (1997).
   PubMedGoogle Scholar
• Agha A, Tomlinson JW, Clark PM, Holder G, Stewart PM. The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic–pituitary-adrenal axis. J. Clin. Endocrinol. Metab.91, 43–47 (2006).
   PubMed Web of Science ®Google Scholar
• Darzy KH, Shalet SM. Absence of adrenocorticotropin (ACTH) neurosecretory dysfunction but increased cortisol concentrations and production rates in ACTH-replete adult cancer survivors after cranial irradiation for nonpituitary brain tumors. J. Clin. Endocrinol. Metab.90, 5217–5225 (2005).
   PubMed Web of Science ®Google Scholar
• Moore JS, Monson JP, Kaltsas G et al. Modulation of 11b-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. J. Clin. Endocrinol. Metab.84, 4172–4177 (1999).
   PubMed Web of Science ®Google Scholar
• Ricardi U, Corrias A, Einaudi S et al. Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.50, 1287–1294 (2001).
   PubMedGoogle Scholar
• Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R. Radiotherapy-induced thyroid disorders. Cancer Treat. Rev.30, 369–384 (2004).
   PubMed Web of Science ®Google Scholar
• Caron PJ, Nieman LK, Rose SR, Nisula BC. Deficient nocturnal surge of thyrotropin in central hypothyroidism. J. Clin. Endocrinol. Metab.62, 960–964 (1986).
   PubMedGoogle Scholar
• Rose SR, Nisula BC. Circadian variation of thyrotropin in childhood. J. Clin. Endocrinol. Metab.68, 1086–1090 (1989).
   PubMedGoogle Scholar
• Paulino AC. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.53, 543–547 (2002).
   PubMed Web of Science ®Google Scholar
• Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR. Thyroid function after treatment of brain tumors in children. J. Pediatr.119, 733–737 (1991).
   PubMed Web of Science ®Google Scholar
• Oberfield SE, Allen JC, Pollack J, New MI, Levine LS. Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function. J. Pediatr.108, 219–223 (1986).
   PubMed Web of Science ®Google Scholar
• Rose SR, Lustig RH, Pitukcheewanont P et al. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J. Clin. Endocrinol. Metab.84, 4472–4479 (1999).
   PubMed Web of Science ®Google Scholar
• Darzy KH, Shalet SM. Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors. J. Clin. Endocrinol. Metab.90, 6490–6497 (2005).
   PubMedGoogle Scholar
• Brada M, Rajan B, Traish D et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin. Endocrinol.38, 571–578 (1993).
   PubMed Web of Science ®Google Scholar
• Merchant TE, Kiehna EN, Sanford RA et al. Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984–2001. Int. J. Radiat. Oncol. Biol.53, 533–542 (2002).
   PubMed Web of Science ®Google Scholar
• Habrand JL, Ganry O, Couanet D et al. The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int. J. Radiat. Oncol. Biol. Phys.44, 255–263 (1999).
   PubMed Web of Science ®Google Scholar
• Pai HH, Thornton A, Katznelson L et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int. J. Radiat. Oncol. Biol.49, 1079–1092 (2001).
   PubMed Web of Science ®Google Scholar
• Constine LS, Rubin P, Woolf PD, Doane K, Lush CM. Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies. J. Clin. Oncol.5, 1841–1851 (1987).
   PubMedGoogle Scholar
• Petterson T, MacFarlane IA, Foy PM, Hughes HJ, Jones B, Shaw D. hyperprolactinemia and infertility following cranial irradiation for brain tumours: successful treatment with bromocriptine. Br. J. Neurosurg.7, 571–574 (1993).
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Murray RD, Columb B, Gleeson HK, Shalet SM. Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic–pituitary axis. Clin. endocrinol.59, 743–748 (2003).
   PubMedGoogle Scholar
• Ganz JC, Aanderud S, Mork SJ, Smievoll AI. Tumour volume reduction following gamma knife radiosurgery: the relationship between x-ray and histological findings. Acta Neurochir. Suppl.62, 39–42 (1994).
   PubMedGoogle Scholar
• Ganz JC, Backlund EO, Thorsen FA. The effects of gamma knife surgery of pituitary adenomas on tumor growth and endocrinopathies. Stereotact. Funct. Neurosurg.61(Suppl. 1), 30–37 (1993).
   PubMedGoogle Scholar
• Tan BC, Kunaratnam N. Hypopituitary dwarfism following radiotherapy for nasopharyngeal carcinoma. Clin. Radiol.17, 302–304 (1966).
   PubMedGoogle Scholar
• Huang TS, Lui LT, Hsu MM, Chen FW. Effect of cranial irradiation on hypothalamus-pituitary function: follow-up study one year after radiotherapy.J. Formos. Med. Assoc.90, 652–658 (1991).
   PubMedGoogle Scholar
• Huang TS, Huang SC, Hsu MM. A prospective study of hypothalamus pituitary function after cranial irradiation with or without radiosensitizing chemotherapy. J. Endocrinol. Invest.17, 615–623 (1994).
   PubMed Web of Science ®Google Scholar
• Sham J, Choy D, Kwong PW et al. Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio. Int. J. Radiat. Oncol. Biol. Phys.29, 699–704 (1994).
   PubMedGoogle Scholar
• Richards GE, Wara WM, Grumbach MM, Kaplan SL, Sheline GE, Conte FA. Delayed onset of hypopituitarism: sequelae of therapeutic irradiation of central nervous system, eye, and middle ear tumors. J. Pediatr.89, 553–559 (1976).
   PubMedGoogle Scholar
• Harrop JS, Davies TJ, Capra LG, Marks V. Hypothalamic–pituitary function following successful treatment of intracranial tumours. Clin. Endocrinol.5, 313–321 (1976).
   PubMedGoogle Scholar
• Evans AE. Central Nervous System Involvement in Children with Acute Leukemia; a Study of 921 Patients. Cancer17, 256–258 (1964).
   PubMedGoogle Scholar
• Chessells JM, Bailey C, Richards SM. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical research council working party on childhood leukaemia. Lancet345, 143–148 (1995).
   PubMed Web of Science ®Google Scholar
• Blatt J, Bercu BB, Gillin JC, Mendelson WB, Poplack DG. Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J. Pediatr.104, 182–186 (1984).
   PubMedGoogle Scholar
• Crowne EC, Wallace WH, Gibson S, Moore CM, White A, Shalet SM. Adrenocorticotrophin and cortisol secretion in children after low dose cranial irradiation. Clin. Endocrinol.39, 297–305 (1993).
   PubMedGoogle Scholar
• Lando A, Holm K, Nysom K et al. Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation. Clin. Endocrinol.55, 21–25 (2001).
   PubMed Web of Science ®Google Scholar
• Vance ML. Hypopituitarism. N. Engl. J. Med.330, 1651–1662 (1994).
   PubMed Web of Science ®Google Scholar
• Tomlinson JW, Holden N, Hills RK et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet357, 425–431 (2001).
   PubMed Web of Science ®Google Scholar
• Suit H, Urie M. Proton beams in radiation therapy. J. Natl Cancer Inst.84, 155–164 (1992).
   PubMed Web of Science ®Google Scholar